CardioPET®   Print Screen
* FluoroPharma

Initial focus is the development of novel PET imaging agents for efficient detection and assessment of acute and chronic forms of coronary disease without a stress test.

CardioPET is one of the first cardiac metabolic imaging agents available for PET, allowing the detection of regions of metabolic insufficiency to be assessed while patients are at rest, of vital importance for those who cannot undergo the exertion of a standard treadmill stress test.

CardioPET will also support emergency room evaluation of chest pain – true diagnosis of heart attack can be made within 30 minutes of CardioPET injection, providing real identification of damaged myocardial tissue.

CardioPET Detects Regions of Metabolic Insufficiency: Internal Blockage Prevents the Metabolism of the Modified Fatty Acid CardioPET by Cell Mitochondria


© Copyright 2007 - QuantRx® Biomedical Corporation
<% newsCon.close set newsCon = nothing contentCon.close set contentCon = nothing %>